These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis. Bernardi RM; Holler SR; Almeida EGC; Anton C; Machado FD; Silva DR Rev Iberoam Micol; 2022; 39(2):31-35. PubMed ID: 35461766 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Wu Z; Wang L; Tan L; Wu J; Chen Z; Hu M Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115274. PubMed ID: 33453546 [TBL] [Abstract][Full Text] [Related]
49. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock. Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781 [TBL] [Abstract][Full Text] [Related]
50. Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients. Ghazanfari M; Arastehfar A; Davoodi L; Yazdani Charati J; Moazeni M; Abastabar M; Haghani I; Mirzakhani R; Mayahi S; Fang W; Liao W; Nguyen MH; Perlin DS; Hoenigl M; Pan W; Hedayati MT Front Med (Lausanne); 2021; 8():649675. PubMed ID: 34195207 [No Abstract] [Full Text] [Related]
51. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory. Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440 [TBL] [Abstract][Full Text] [Related]
52. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid. Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis. Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824 [TBL] [Abstract][Full Text] [Related]
54. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis. Lu Y; Liu L; Li H; Chen B; Gu Y; Wang L; Feng C; Chen C; Chen Y; Sun W; Cui X; Cao M; Tao Y; Zhong J; Zhong H; Ni Y; Cai Y; Song M; Liu X; Shi Y; Su X Clin Microbiol Infect; 2023 Jun; 29(6):797.e1-797.e7. PubMed ID: 36773771 [TBL] [Abstract][Full Text] [Related]